FOXL2 Activators
FOXL2 Activators encompass a diverse array of chemical compounds that enhance the activity of FOXL2 through various signaling pathways and biological processes. Forskolin and Dibutyryl-cAMP are agents that elevate intracellular cAMP, thereby activating protein kinase A (PKA), which could phosphorylate proteins that increase FOXL2's transcriptional activity. The influence of Forskolin extends to the adenylate cyclase pathway, further linking cAMP levels to potential upregulation of FOXL2. Fadrozole, by inhibiting aromatase, may upregulate FOXL2 through a compensatory mechanism in tissues responsive to estrogen fluctuations. PI3K/AKT pathway modulation through LY294002 could enhance FOXL2 activity by interfering with negative feedback loops, while Rapamycin's inhibition of mTOR signaling might shift cellular focus towards differentiation processes, thereby potentially increasing FOXL2 activity.
In parallel, chemical modifiers like Trichostatin A and Sodium butyrate serve as epigenetic tools, promoting chromatin remodeling and potentially facilitating FOXL2 transcription by increasing the accessibility of its gene locus. PD98059's influence on the MAPK/ERK pathway may lead to an indirect increase in FOXL2 activity by triggering compensatory regulatory mechanisms. GW501516's activation of PPARδ and AICAR's influence on AMPK signaling are thought to induce broad transcriptional changes that could encompass upregulation of FOXL2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates protein kinase A (PKA). PKA phosphorylation can enhance transcription factors activities, potentially increasing the transcriptional activity of FOXL2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing intracellular cAMP levels and thereby activating PKA. PKA may then augment FOXL2 activity by phosphorylating associated factors. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which could indirectly increase FOXL2 activity by shifting cellular resources from growth processes to differentiation processes where FOXL2 is involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that may alter MAPK/ERK pathway signaling, potentially leading to a compensatory increase in FOXL2 activity. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 activates PPARδ, leading to altered gene expression. This activation may indirectly enhance FOXL2 activity through changes in the transcriptional program of the cell. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can lead to a variety of downstream effects including transcriptional changes that could upregulate FOXL2 expression or activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression through retinoic acid receptors. It could enhance FOXL2 activity by promoting differentiation pathways where FOXL2 plays a role. | ||||||
Zearalenone | 17924-92-4 | sc-204943 sc-204943A | 10 mg 50 mg | $120.00 $369.00 | 6 | |
Zearalenone acts as an estrogen receptor agonist, which could influence the transcriptional activity of FOXL2 in estrogen-responsive tissues. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that acts as a histone deacetylase inhibitor, potentially increasing FOXL2 expression by creating a more accessible chromatin state. | ||||||